Farmington, CTNCT06846853Now EnrollingIRB Ready

Contrast Enhanced Images vs. Non-contrast Images Clinical Trial in Farmington, CT

Access cutting-edge contrast enhanced images vs. non-contrast images treatment through this clinical trial at a research site in Farmington. Study-provided care at no cost to qualified participants.

Sponsored by UConn Health

Quick Self-Assessment

See if you qualify for this Farmington location

Preparing your pre-screening questions…

Expert Care in Farmington

Access contrast enhanced images vs. non-contrast images specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related contrast enhanced images vs. non-contrast images treatment provided free

Apply for This Farmington Location

Check if you qualify for this contrast enhanced images vs. non-contrast images clinical trial in Farmington, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Farmington

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Farmington site if eligible
  4. 4Begin participation

About This Contrast Enhanced Images vs. Non-contrast Images Study in Farmington

This study will evaluate the efficacy and safety of Gadopiclenol, an FDA-approved contrast agent, for visualizing pituitary lesions on MR images by comparing with the comparator, Gadobutrol, a clinically widely used contrast agent. The study is double-blinded, so neither the participants nor the researchers know which contrast agent is being used during each scan to avoid the bias of results.

Sponsor: UConn Health

Who Can Participate

Inclusion Criteria

Male adult patient who is at 18 years old or above, or female adult patient who is at 55 years old or above.
Patient presenting with known or highly suspected pituitary lesion(s) with focal areas of disrupted Blood Brain Barrier (BBB) (e.g., primary and secondary tumors) based on results of a previous imaging procedure such as Computed Tomography (CT) or MRI, which should have been performed within 12 months prior to informed consent form signature.
Patient scheduled for a contrast-enhanced MRI examination with a focus on pituitary for clinical reasons and agreeing to have a second contrast-enhanced MRI examination for the purpose of the trial.
If the patient was treated (either with radiation, surgery, biopsy or other relevant treatments) for a pituitary condition between previous imaging evaluation and trial MRI, there should still be a high suspicion of remaining lesion(s) on the basis of available clinical information.
Patient able and willing to participate in the trial.
Patient having read the information and having provided his/her consent to participate in writing by dating and signing the informed consent prior to any trial related procedure being conducted.
Patient affiliated to national health insurance according to local regulatory requirements.

Exclusion Criteria

Patient presenting with known class III/IV congestive heart failure according to the New York Heart Association classification (NYHA).
Patient having received any investigational medicinal product within 7 days prior to trial entry or scheduled to receive any investigational treatment in the course of the trial.
Patient presenting with any contraindication to MRI examinations.
Patient previously randomized in this trial.
Patient having received any contrast agent (MRI or CT) within 3 days prior to first trial product administration, or scheduled to receive any contrast agent during the course of the trial or within 24 hours after the second trial product administration
Patient expected/scheduled to have any treatment or medical procedure (e.g. chemotherapy, radiotherapy, biopsy or surgery etc.) that may impact the aspects of the imaged lesions between the 2 MRI examinations. (Patients under corticosteroids and/or maintenance chemotherapy with a stable dose at the time of screening visit and throughout the trial can be included). Patient with anticipated, current or past condition (medical, psychological, social or geographical) that would compromise the patient's safety or her/his ability to participate in the trial. 8\. Patient unlikely to comply with the protocol, e.g. uncooperative attitude, inability to return for follow-up visits and/or unlikelihood of completing the trial. 9\. Patient related to the investigator or any other trial staff or relative directly involved in the trial conduct. 10. Patient presenting with acute or chronic renal insufficiency, defined as an estimated Glomerular Filtration Rate (eGFR) \< 30 mL/min/1.73 m² assessed within 1 day prior to each contrast agent injection. 11. Patient with known contra-indication(s) to the use or with known sensitivity to one of the products under investigation or to other GBCAs (such as hypersensitivity, post contrast acute kidney injury). 12\. Patient who are prisoners, pregnant women, or educationally disadvantaged persons known as vulnerable population will be excluded as well to protect the rights and welfare of these participants.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Farmington?

Yes, this clinical trial (NCT06846853) has an active research site in Farmington, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Contrast Enhanced Images vs. Non-contrast Images Treatment Options in Farmington, CT

If you're searching for contrast enhanced images vs. non-contrast images treatment options in Farmington, CT, this clinical trial (NCT06846853) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Farmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced contrast enhanced images vs. non-contrast images specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all contrast enhanced images vs. non-contrast images clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Farmington, CT

See all rheumatoid arthritis clinical trials recruiting in Farmington — not just this study.

Browse Rheumatoid Arthritis Trials in Farmington →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in Farmington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Farmington, CT